Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, 20 Chazhong Road, Taijiang, Fuzhou, Fujian, 350004, People's Republic of China.
Langenbecks Arch Surg. 2021 Mar;406(2):283-299. doi: 10.1007/s00423-020-01934-8. Epub 2020 Sep 2.
To compare natural orifice specimen extraction surgery (NOSES) and conventional laparoscopic (LAP) surgery in treating colorectal cancer.
The present authors conducted a systematic search in the PubMed, EMBASE, and Cochrane databases for randomized controlled trials (RCTs), prospective nonrandomized studies, and retrospective studies up to May 2019. We used postoperative complications as the main endpoints, and used hospital stay, time to first flatus, operative time, postoperative pain, cosmetic result, wound infections, and oncological outcomes as the secondary endpoints. Subgroup analyses were conducted according to the different specimen extraction sites (transanal and transvaginal). A sensitivity analysis was carried out to evaluate the reliability of the outcomes. RevMan5.3 software was used for statistical analysis.
Twelve studies (one RCT, ten retrospective studies, and one prospective nonrandomized study) involving a total of 1437 patients (NOSES group 665 patients and LAP surgery group 772 patients) were included. Meta-analysis showed that compared with LAP surgery, NOSES resulted in a shorter hospital stay (WMD = -0.79 days; 95% CI -1.17 to -0.42; P < 0.001; P = 0.02), a shorter time to first flatus (WMD = -0.58 days; 95% CI -0.75 to -0.40; P < 0.001), less postoperative pain (WMD = -1.51; 95% CI -1.99 to -1.04; P < 0.001), a better cosmetic result (WMD = 1.37; 95% CI 0.59 to 2.14; P < 0.001), and fewer wound infections (OR = 0.13; 95% CI 0.05 to 0.35; P < 0.001) and postoperative complications (OR = 0.48; 95% CI 0.36 to 0.65; P < 0.001). Oncological outcomes did not differ between the two groups, while the operative time (WMD = 13.95 min; 95% CI 4.55 to 23.35; P = 0.004) was longer in the NOSES group.
The present systematic meta-analysis is an attempt to assess the impact of NOSES, namely, its oncological outcomes and surgical safety in colorectal cancer patients. Pooled comparisons revealed that NOSES was superior to LAP surgery in terms of postoperative morbidity, postoperative pain, hospital stay, the time to first flatus, cosmetic results, and wound infections; however, NOSES was associated with a longer operative time. Considering the abovementioned limitations and the very low level of evidence of the comparisons, further RCTs are required to verify the results of our study.
比较经自然腔道取标本手术(NOSES)与传统腹腔镜(LAP)手术治疗结直肠癌的效果。
本研究系统检索了 PubMed、EMBASE 和 Cochrane 数据库,检索时间截至 2019 年 5 月,纳入随机对照试验(RCT)、前瞻性非随机研究和回顾性研究。以术后并发症为主要结局,以住院时间、首次肛门排气时间、手术时间、术后疼痛、美容效果、切口感染和肿瘤学结局为次要结局。根据不同的标本取出部位(经肛门和经阴道)进行亚组分析。采用敏感性分析评估结果的可靠性。采用 RevMan5.3 软件进行统计学分析。
共纳入 12 项研究(1 项 RCT、10 项回顾性研究和 1 项前瞻性非随机研究),共计 1437 例患者(NOSES 组 665 例,LAP 手术组 772 例)。Meta 分析结果显示,与 LAP 手术相比,NOSES 可使住院时间更短(WMD=-0.79 天;95%CI:-1.17 至-0.42;P<0.001;P=0.02),首次肛门排气时间更早(WMD=-0.58 天;95%CI:-0.75 至-0.40;P<0.001),术后疼痛更轻(WMD=-1.51;95%CI:-1.99 至-1.04;P<0.001),美容效果更好(WMD=1.37;95%CI:0.59 至 2.14;P<0.001),切口感染更少(OR=0.13;95%CI:0.05 至 0.35;P<0.001),术后并发症发生率更低(OR=0.48;95%CI:0.36 至 0.65;P<0.001)。两组的肿瘤学结局无差异,而 NOSES 组的手术时间更长(WMD=13.95 分钟;95%CI:4.55 至 23.35;P=0.004)。
本系统评价旨在评估 NOSES 在结直肠癌患者中的应用效果,包括其肿瘤学结局和手术安全性。汇总分析结果显示,NOSES 在术后发病率、术后疼痛、住院时间、首次肛门排气时间、美容效果和切口感染方面优于 LAP 手术,但手术时间更长。考虑到上述局限性和比较的证据水平非常低,需要进一步的 RCT 来验证本研究的结果。